Synopsys (SNPS) Research & Development (2009 - 2026)

Synopsys (SNPS) has reported Research & Development for 18 consecutive years, with $715.0 million the latest figure, recorded in Q1 2026.

• Research & Development for Q1 2026 came in at $715.0 million, up 29.24% year-over-year; the trailing twelve-month figure through Jan 2026 was $2.6 billion (up 25.17% YoY), and the FY2025 annual result was $2.5 billion, up 19.06% from the prior year.
• Research & Development was $715.0 million for Q1 2026 at Synopsys, down from $746.8 million in the prior quarter.
• Over five years, Research & Development peaked at $746.8 million in Q4 2025 and troughed at $371.1 million in Q4 2022.
• A 5-year average of $514.3 million and a median of $493.1 million in 2024 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2022 — Research & Development declined 10.34% — and 2025, when it soared 34.61%.
• Year by year, Research & Development stood at $371.1 million in 2022, then gained by 25.53% to $465.8 million in 2023, then rose by 19.11% to $554.8 million in 2024, then jumped by 34.61% to $746.8 million in 2025, then retreated by 4.27% to $715.0 million in 2026.
• Per Business Quant, the three latest SNPS Research & Development figures stand at $715.0 million (Q1 2026), $746.8 million (Q4 2025), and $625.3 million (Q3 2025).